RESUMO
OBJECTIVE: Assessment of thrombus inflammation in vivo could provide new insights into deep vein thrombosis (DVT) resolution. Here, we develop and evaluate 2 integrated fluorescence molecular-structural imaging strategies to quantify DVT-related inflammation and architecture and to assess the effect of thrombus inflammation on subsequent DVT resolution in vivo. METHODS AND RESULTS: Murine DVT were created with topical 5% FeCl(3) application to thigh or jugular veins (n=35). On day 3, mice received macrophage and matrix metalloproteinase activity fluorescence imaging agents. On day 4, integrated assessment of DVT inflammation and architecture was performed using confocal fluorescence intravital microscopy. Day 4 analyses showed robust relationships among in vivo thrombus macrophages, matrix metalloproteinase activity, and fluorescein isothiocyanate-dextran deposition (r>0.70; P<0.01). In a serial 2-time point study, mice with DVT underwent intravital microscopy at day 4 and day 6. Analyses revealed that the intensity of thrombus inflammation at day 4 predicted the magnitude of DVT resolution at day 6 (P<0.05). In a second approach, noninvasive fluorescence molecular tomography-computed tomography was used and detected macrophages within jugular DVT (P<0.05 versus sham controls). CONCLUSIONS: Integrated fluorescence molecular-structural imaging demonstrates that the DVT-induced inflammatory response can be readily assessed in vivo and can inform the magnitude of thrombus resolution.
Assuntos
Inflamação/patologia , Microscopia Confocal , Microscopia de Fluorescência , Imagem Molecular/métodos , Trombose Venosa/patologia , Animais , Biomarcadores/metabolismo , Cloretos , Dextranos , Modelos Animais de Doenças , Veia Femoral/imunologia , Veia Femoral/metabolismo , Veia Femoral/patologia , Compostos Férricos , Fluoresceína-5-Isotiocianato/análogos & derivados , Corantes Fluorescentes , Inflamação/induzido quimicamente , Inflamação/diagnóstico por imagem , Inflamação/imunologia , Inflamação/metabolismo , Veias Jugulares/imunologia , Veias Jugulares/metabolismo , Veias Jugulares/patologia , Macrófagos/imunologia , Macrófagos/patologia , Masculino , Metaloproteinases da Matriz/metabolismo , Camundongos , Camundongos Endogâmicos C57BL , Flebografia , Prognóstico , Reprodutibilidade dos Testes , Veia Safena/imunologia , Veia Safena/metabolismo , Veia Safena/patologia , Índice de Gravidade de Doença , Fatores de Tempo , Tomografia Computadorizada por Raios X , Trombose Venosa/induzido quimicamente , Trombose Venosa/diagnóstico por imagem , Trombose Venosa/imunologia , Trombose Venosa/metabolismoRESUMO
BACKGROUND: Inflammation within vulnerable coronary plaques may cause unstable angina by promoting rupture and erosion. In unstable angina, activated leukocytes may be found in peripheral and coronary-sinus blood, but it is unclear whether they are selectively activated in the vascular bed of the culprit stenosis. METHODS: We measured the content neutrophil myeloperoxidase content in the cardiac and femoral circulations in five groups of patients: two groups with unstable angina and stenosis in either the left anterior descending coronary artery (24 patients) or the right coronary artery (9 patients); 13 with chronic stable angina; 13 with variant angina and recurrent ischemia; and 6 controls. Blood samples were taken from the aorta, the femoral vein, and the great cardiac vein, which selectively drains blood from the left but not the right coronary artery. RESULTS: The neutrophil myeloperoxidase content of aortic blood was similar in both groups of patients with unstable angina (-3.9 and -5.5, with negative values representing depletion of the enzyme due to neutrophil activation) and significantly lower than in the other three groups (P<0.05). Independently of the site of the stenosis, the neutrophil myeloperoxidase content in blood from the great cardiac vein was significantly decreased in both groups of patients with unstable angina (-6.4 in those with a left coronary lesion and -6.6 in those with a right coronary lesion), but not in patients with stable angina and multiple stenoses, patients with variant angina and recurrent ischemia, or controls. There was also a significant transcoronary reduction in myeloperoxidase content in both groups with unstable angina. CONCLUSIONS: The widespread activation of neutrophils across the coronary vascular bed in patients with unstable angina, regardless of the location of the culprit stenosis, challenges the concept of a single vulnerable plaque in unstable coronary syndromes.
Assuntos
Angina Instável/imunologia , Circulação Coronária/imunologia , Estenose Coronária/imunologia , Ativação de Neutrófilo , Idoso , Angina Pectoris/sangue , Angina Pectoris/imunologia , Angina Instável/sangue , Aorta/imunologia , Biomarcadores/sangue , Proteína C-Reativa/metabolismo , Cateterismo Venoso Central , Cateterismo Periférico , Estenose Coronária/sangue , Feminino , Veia Femoral/imunologia , Humanos , Inflamação , Dinitrato de Isossorbida/administração & dosagem , Masculino , Pessoa de Meia-Idade , Isquemia Miocárdica/sangue , Isquemia Miocárdica/imunologia , Neutrófilos/enzimologia , Peroxidase/sangue , Estatísticas não Paramétricas , Vasodilatadores/administração & dosagemRESUMO
Although intimal hyperplasia is a major cause limiting the long-term patency of the vein grafts, its precise mechanisms, including the effect of poor runoff, has not yet been well characterized. We thus designed the present study to try to determine the effect of poor runoff arterial flow to the phenotypic alterations of the graft wall by immnohistochemistry using anti-intermediate filaments (alpha-SM actin, desmin, and vimentin) and anti-myosin heavy chain (SM1, SM2, and SMemb) specific antibodies. Vein grafts implanted under the poor runoff hind limb of rabbits showed enhanced intimal hyperplasia, however, no apparent difference in the cytoskeleton expression, including intermediate filaments and MHC, between two groups until 4 weeks. Interestingly, six of eight vein grafts at 2 weeks after implantation in both groups showed the accumulations of perivascular fibroblast-like phenotype (negative for SM1, alpha-SM actin, and desmin) in some parts of the outer neointima, whereas the inner neointima at 2 weeks and the whole neointima at 4 weeks were mainly occupied by a smooth muscle phenotype (positive for these three). Although the cellular origin of these cells is still unknown, these results suggest that the migration of non-muscle mesenchymal cells is involved in the neointima and thus may provide a clue for better understanding vein graft remodeling.
Assuntos
Artéria Femoral/cirurgia , Veia Femoral/imunologia , Veia Femoral/transplante , Proteínas de Filamentos Intermediários/imunologia , Cadeias Pesadas de Miosina/imunologia , Anastomose Cirúrgica , Animais , Arteriopatias Oclusivas/metabolismo , Arteriopatias Oclusivas/fisiopatologia , Arteriopatias Oclusivas/cirurgia , Velocidade do Fluxo Sanguíneo , Prótese Vascular , Veia Femoral/metabolismo , Veia Femoral/patologia , Fibroblastos/patologia , Membro Posterior/irrigação sanguínea , Proteínas de Filamentos Intermediários/metabolismo , Masculino , Músculo Liso Vascular/metabolismo , Músculo Liso Vascular/patologia , Cadeias Pesadas de Miosina/metabolismo , Fenótipo , Coelhos , Transplante Autólogo/imunologia , Transplante Autólogo/patologia , Túnica Íntima/metabolismo , Túnica Íntima/patologiaRESUMO
Small diameter arterial reconstruction is usually achieved by use of the autologous long saphenous vein. As an alternative to this blood conduit, the venous allograft has been used with some success in the past, but is likely to be the target of an immune rejection reaction from the host. This study was designed to characterize humoral immune reactions possibly involved in the outcome of venous allografts. Ten mongrel dogs received a histoincompatible femoral vein allograft and an autograft as interposition grafts to both femoral arteries. They were investigated for donor-specific antibody development using donor splenocytes and cultured vascular endothelial cells (EC). Serum samples were collected at surgery, at 2 weeks, and every month until graft occlusion occurred. All autografts were patent at retrieval except one, and all allografts underwent thrombosis. In all dogs, donor-specific IgG development was observed that appeared specifically at 4 weeks and lasted until graft occlusion was detected. All reactive sera were cytotoxic to donor EC except one, and this reactivity was completely lost after serum absorption on donor splenocytes. This latter absorption resulted in the total loss of flow cytometric reactivity against donor EC in 3 dogs, whereas a low reactivity was still present in 4 dogs. Immunoblotting analysis showed a posttransplant reactivity against various protein bands on donor EC. Absorption of the reactive serum on donor splenocytes resulted in the loss of reactivity to proteins of approximately 40, 30, and 22 kDa in most experiments. Moreover, as demonstrated by immunofluorescence on cryostat sections of explanted grafts, IgG deposition was seen mainly in the media and the adventitia of the allografts but not in autografts. These results suggest that a donor-specific antibody response directed mainly against MHC antigens might play a role in the thrombosis of histoincompatible venous allografts, thus decreasing the patency rate.
Assuntos
Anticorpos/imunologia , Veia Femoral/imunologia , Veia Femoral/transplante , Rejeição de Enxerto/imunologia , Animais , Formação de Anticorpos/imunologia , Especificidade de Anticorpos , Coagulação Sanguínea , Células Cultivadas , Citotoxicidade Imunológica , Cães , Endotélio Vascular/citologia , Endotélio Vascular/imunologia , Feminino , Citometria de Fluxo , Imunofluorescência , Immunoblotting , Masculino , Trombose , Grau de Desobstrução VascularRESUMO
To date, no arterial substitute has been shown to be as effective as the autologous saphenous vein in peripheral revascularization procedures. In the present study, the venous allograft was evaluated as a vascular substitute in terms of patency and induction of host immune reactivity, whether used in major histocompatibility complex-incompatible, major histocompatibility complex-incompatible dogs. The immunosuppressive drug therapies were given for a period of 31 days, beginning 1 day before transplantation, and consisted of the use of cyclosporine A, mycophenolate mofetil, or a combination of both. All histoincompatible allografts were thrombosed at 4 or 8 weeks after transplantation with antibody development and cell-mediated cytotoxicity in the graft, whereas histocompatible allografts showed late stenosis without immunologic reactions directed toward donor cells. Given alone, neither cyclosporine A nor mycophenolate mofetil improved the overall patency of venous allografts; thrombosis occurred shortly after cessation of immunosuppression. Still, the cyclosporine A-mycophenolate mofetil combination therapy led to a 100% patency rate at 20 weeks after implantation and immune reactions were markedly reduced. This study shows that the fresh vein allograft is still an attractive and functional alternative to the autologous saphenous vein if the host immunologic reactions are controlled by cyclosporine A-mycophenolate mofetil immunosuppression.
Assuntos
Prótese Vascular , Ciclosporina/uso terapêutico , Artéria Femoral/cirurgia , Veia Femoral/transplante , Rejeição de Enxerto/prevenção & controle , Imunossupressores/uso terapêutico , Ácido Micofenólico/análogos & derivados , Animais , Cães , Quimioterapia Combinada , Feminino , Veia Femoral/imunologia , Veia Femoral/ultraestrutura , Oclusão de Enxerto Vascular/etiologia , Rejeição de Enxerto/imunologia , Masculino , Microscopia Eletrônica de Varredura , Ácido Micofenólico/uso terapêutico , Fatores de Tempo , Transplante Autólogo , Transplante Homólogo , Grau de Desobstrução VascularRESUMO
Fresh venous allografts were investigated in dogs matched according to donor-recipient tissue compatibility, either originating from the same litter or chosen at random (pound dogs). Five centimeter long segments of femoral vein were interposed as carotid substitutes in an autografting and allografting manner between paired dogs. During a 5-month implantation period, donor-specific antibody development was measured in the recipient serum by a flow-cytometric assay using cultured donor vascular endothelial cells. Autografts and allografts were investigated in terms of patency, histopathology, and endothelial cell function. Fifteen of 16 autografts remained patent. Allografts between littermate dogs, whether compatible or incompatible, showed no donor-specific antibody development and were all patent at retrieval. Compatible and incompatible allografts in littermates did not show any difference in prostacyclin (PGI2)/thromboxane A2 (TXA2) ratios. In pound dogs, both compatible allografts were patent and one dog developed donor-specific antivascular endothelial cell antibodies. Among incompatible dogs, antibody formation was detected at 1 month in five of six recipients and graft patency was as follows: two partial thromboses, two stenoses, and two patent grafts. The PGI2/TXA2 ratio was significantly lower in incompatible allografts than in compatible ones (p = .028). These results show the importance of donor-recipient histocompatibility matching in improving the outcome of vein allografts.
Assuntos
Prótese Vascular , Artérias Carótidas/cirurgia , Veia Femoral/transplante , Histocompatibilidade , Isoanticorpos/biossíntese , Animais , Artérias Carótidas/imunologia , Artérias Carótidas/patologia , Células Cultivadas , Cães , Endotélio Vascular/imunologia , Endotélio Vascular/patologia , Epoprostenol/biossíntese , Feminino , Veia Femoral/imunologia , Veia Femoral/patologia , Oclusão de Enxerto Vascular , Hiperplasia , Masculino , Microscopia Eletrônica de Varredura , Núcleo Familiar , Complicações Pós-Operatórias , Período Pós-Operatório , Trombose/etiologia , Tromboxano A2/biossíntese , Doadores de Tecidos , Transplante Autólogo , Transplante Homólogo/imunologiaRESUMO
The direct immunofluorescence procedure was used to demonstrate immune complexes (fixed immunoglobulins) in the internal and external sheath of veins of a dog with experimental acute thrombosis caused by partial ligation of the ileofemoral vein in the presence of immunization of the animal with extracts of auto- and homologous vein tissue. The results suggest the participation of auto-immune processes in the pathogenesis of acute thrombosis of the main veins.
Assuntos
Veia Femoral/imunologia , Veia Ilíaca/imunologia , Trombose/imunologia , Doença Aguda , Animais , Doenças Autoimunes/imunologia , Doenças Autoimunes/patologia , Cães , Veia Femoral/patologia , Humanos , Veia Ilíaca/patologia , Recidiva , Trombose/patologia , Fatores de TempoRESUMO
OBJECTIVE: Oxidized lipoproteins and antioxidized LDL antibodies (antioxLDL abs) have been detected in human plasma and atherosclerotic lesions. The principle aim of this study was to analyze the possible relationship between IgG and IgM antioxLDL abs and factors involved in different metabolic pathways (inflammation, lipid metabolism, apoptosis, and cell cycle arrest profile) in the occluded popliteal artery (OPA) compared with the femoral vein (FV). RESEARCH DESIGN AND METHODS: Fifteen patients with advanced atherosclerosis and type 2 diabetes undergoing lower limb amputation participated in this study. Each patient had OPA and FV biopsy specimens and peripheral arterial occlusive disease. By real-time PCR, gene expression was analyzed from the OPA and FV specimens, and antioxLDL ab levels were measured by specific enzyme-linked immunosorbent assay. RESULTS: The OPA and FV showed a positive correlation between only IgM antioxLDL ab levels and the expression of genes involved in different metabolic pathways, including inflammation (TFPI), apoptosis (BAX, caspase 3, AKT1), plaque disruption (MMP2 and MMP10), lipid metabolism (SCARB1, PPARg), and cell turnover (CDKN1A), and genes for transcription and growth factors (NFkB and VEGFA, respectively). CONCLUSIONS: The results show that gene expression in the metabolic pathways (apoptosis, lipid metabolism, and inflammation) in the OPA and FV are directly related to the levels of IgM antioxLDL abs.
Assuntos
Anticorpos/imunologia , Diabetes Mellitus Tipo 2/imunologia , Diabetes Mellitus Tipo 2/metabolismo , Placa Aterosclerótica/imunologia , Placa Aterosclerótica/metabolismo , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Veia Femoral/imunologia , Veia Femoral/metabolismo , Humanos , Imunoglobulina G/imunologia , Imunoglobulina M/imunologia , Lipoproteínas LDL/imunologia , Masculino , Redes e Vias Metabólicas/imunologia , Redes e Vias Metabólicas/fisiologia , Pessoa de Meia-Idade , Artéria Poplítea/imunologia , Artéria Poplítea/metabolismo , Reação em Cadeia da Polimerase em Tempo Real , Adulto JovemRESUMO
OBJECTIVE AND DESIGN: Emerging data suggest that Rho-kinase signaling may regulate numerous aspects of inflammatory reactions. Herein, we investigated the role of Rho-kinase in inflammatory interactions between leukocytes and the endothelium in femoral arteries and veins in vivo. MATERIAL AND METHODS: Mice were injected with lipopolysaccharide (LPS) and Rho-kinase was inhibited by pre-treatment with fasudil, which is a highly selective inhibitor of Rho-kinase. Six hours after LPS challenge, intravital fluorescence microscopy of the femoral vessels was performed and leukocyte-endothelium interactions were visualized after in vivo staining with rhodamine 6G. RESULTS: LPS increased leukocyte rolling and adhesion in femoral arteries and veins. Pre-treatment with fasudil had no effect on leukocyte rolling but significantly decreased venular leukocyte adhesion by 85% and completely abrogated leukocyte adhesion in femoral arteries in endotoxin-treated mice. CONCLUSIONS: We conclude that Rho-kinase signaling regulates LPS-induced leukocyte adhesion in femoral arteries and veins in vivo and that inhibition of Rho-kinase may be useful in the treatment of pathological inflammation in large blood vessels of the vascular system.
Assuntos
1-(5-Isoquinolinasulfonil)-2-Metilpiperazina/análogos & derivados , Adesão Celular/efeitos dos fármacos , Peptídeos e Proteínas de Sinalização Intracelular/antagonistas & inibidores , Migração e Rolagem de Leucócitos/efeitos dos fármacos , Leucócitos/efeitos dos fármacos , Inibidores de Proteínas Quinases/farmacologia , Proteínas Serina-Treonina Quinases/antagonistas & inibidores , 1-(5-Isoquinolinasulfonil)-2-Metilpiperazina/farmacologia , Animais , Arterite/imunologia , Artéria Femoral/imunologia , Veia Femoral/imunologia , Leucócitos/enzimologia , Lipopolissacarídeos/farmacologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Flebite/imunologia , Quinases Associadas a rhoRESUMO
RATIONALE: Inflammation and thrombosis are related via interactions between leukocytes, platelets, the vasculature, and the coagulation system. However, the mechanisms behind these interactions remain poorly understood. OBJECTIVES: We have investigated the effects of the well known pulmonary inflammation induced by silica for the development of peripheral thrombogenicity in a hamster model of thrombosis. In addition, the consequences of pulmonary macrophage and circulating monocyte and neutrophil depletion on the thrombogenicity were investigated. METHODS: Silica particles (2-200 mug/hamster) were intratracheally instilled, and experimental thrombosis in photochemically induced femoral vein lesions was assessed 24 hours later, in association with cellular infiltration in the lung. MEASUREMENTS AND MAIN RESULTS: Intratracheally instilled silica particles (20 and 200 mug/hamster) triggered pulmonary inflammation, together with stimulation of peripheral platelet-rich thrombus formation. Both the selective depletion of lung macrophages by intratracheal administration of clodronate liposomes and the combined depletion of circulating monocytes and neutrophils by intraperitoneal injection of cyclophosphamide significantly reduced silica-induced influx of macrophages and neutrophils in bronchoalveolar lavage, and reduced peripheral thrombogenicity. Silica-induced lung inflammation was accompanied by increased neutrophil elastase levels in bronchoalveolar lavage and in plasma. Specific neutrophil elastase inhibition in the lung did not affect lung inflammation but reduced peripheral thrombogenicity. CONCLUSION: These findings uncover pulmonary macrophage-neutrophil cross-talk releasing neutrophil elastase into the blood circulation. Elastase, triggering activation of circulating platelets, may then predispose platelets to initiate thrombotic events on mildly damaged vasculature.
Assuntos
Macrófagos Alveolares/imunologia , Neutrófilos/imunologia , Silicose/imunologia , Trombose Venosa/imunologia , Animais , Plaquetas/fisiologia , Líquido da Lavagem Broncoalveolar/imunologia , Cricetinae , Veia Femoral/imunologia , Elastase de Leucócito/sangue , Ativação Plaquetária/imunologia , Receptor Cross-Talk/imunologia , Dióxido de SilícioRESUMO
BACKGROUND: Clinical observation suggests that chronic venous insufficiency is related to failure of venous valves. Duplex ultrasound studies of lower extremity superficial veins regularly show valve failure and venous reflux. Gross morphologic observation of venous valves in surgical specimens shows tearing, splitting, scarring, and disappearance of valves. HYPOTHESIS: Venous valve damage is acquired, linked with venous hypertension, and affected by inflammation. OBJECTIVE: The objective of this study was to investigate the inflammatory process in valve remodeling associated with acute and chronic venous hypertension. METHODS: A femoral arteriovenous fistula was created in study animals (Wistar rats, n = 60), and animals without an arteriovenous fistula were studied as controls (n = 5). At 1, 7, 21, and 42 days animals with the femoral arteriovenous fistula were anesthetized, and systemic pressure, the pressure in the femoral vein distal to fistula, and the pressure of the femoral vein in the contralateral hind limb were measured. Timed collection of blood backflow after division of the femoral vein distal to the fistula and in the alive, anesthetized animal was collected, measured, and calculated per unit time to be used as an indicator of valve insufficiency. The femoral vein distal to the fistula was harvested; valvular structures were examined and measured. Specimens were processed, and longitudinal sections were made and challenged with immunostaining antibodies against matrix metalloprotease (MMP)-2 and MMP-9. Sections were examined, and expression of molecular markers was determined by light absorption measurements after image digitization. RESULTS: One week after the procedure, all animals exhibited some degree of hind limb edema ipsilateral to the arteriovenous fistula. Pressure in the femoral vein distal to the fistula was markedly increased on average to 96 +/- 9 mm Hg. Reflux was increased in a time-dependent manner, with the 21-day and 42-day groups showing the highest values. Valves just distal to the fistula showed an increased diameter of the valvular annulus and a shortening of the annular height. Venous wall findings included fibrosis and fusion of the media and adventitia and scarring and disappearance of valves principally in the 21- and 42-day specimens. Immunolabeling for MMP-2 showed an increased level in the 21- and 42-day groups. MMP-9 showed an increased level at 1 day, followed by a more marked level in the 21- and 42-day groups. CONCLUSIONS: In this animal model of venous hypertension the findings of limb edema, increasing valvular reflux, and morphologic changes of increased annulus diameter and valve height are seen. Histologic changes included massive fibrosis of media and fusion with adventitia. Inflammatory markers MMP-2 and MMP-9 are strongly represented, and valve disappearance occurs after these markers are present. The gross morphologic changes seen are quite similar to those observed in human surgical specimens removed in treatment of venous insufficiency. CLINICAL RELEVANCE: When observed angioscopically at the time of vein stripping, saphenous vein valves show severe deformities including shortening, scarring, and tearing. The current model of induced venous hypertension demonstrates early venous valve changes that replicate those observed in humans. This observation provides a link from venous hypertension to an induced inflammatory reaction that stimulates the valve damage. Thus the model could be useful for defining the fundamental mechanisms that cause venous valve failure and varicose veins and in pharmacologic testing to prevent or treat venous insufficiency.